These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31714378)

  • 21. Surgical treatment of pyoderma gangrenosum following deep inferior epigastric perforator flap breast reconstruction.
    Tamer F; Adışen E; Tuncer S; Gurer MA
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Sep; 25(3):55-56. PubMed ID: 27695868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab as a treatment for recalcitrant pyoderma gangrenosum.
    Singh M; Andrew SM; Lear JT
    Clin Exp Dermatol; 2004 Mar; 29(2):196-7. PubMed ID: 14987282
    [No Abstract]   [Full Text] [Related]  

  • 23. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
    Nybaek H; Jemec GB
    Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study.
    Rousset L; de Masson A; Begon E; Villani A; Battistella M; Rybojad M; Jachiet M; Bagot M; Bouaziz JD; Lepelletier C
    J Am Acad Dermatol; 2019 Apr; 80(4):1141-1143. PubMed ID: 30342166
    [No Abstract]   [Full Text] [Related]  

  • 25. Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.
    Lesmeister LM; Peitz J; von Kleist-Retzow JC; Lee-Kirsch MA; Torrelo A; Tantcheva-Poor I; Broekaert IJ
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e376-e378. PubMed ID: 35037304
    [No Abstract]   [Full Text] [Related]  

  • 26. Dermatologic manifestations of Crohn disease in children: response to infliximab.
    Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
    Stichweh DS; Punaro M; Pascual V
    Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
    Tanczos BT; Baumgart DC
    Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyoderma gangrenosum after inguinal hernia repair.
    Kotzampassakis N; Ksontini R
    Hernia; 2012 Jun; 16(3):345-7. PubMed ID: 21086145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases.
    Tolkachjov SN; Fahy AS; Cerci FB; Wetter DA; Cha SS; Camilleri MJ
    Mayo Clin Proc; 2016 Sep; 91(9):1267-79. PubMed ID: 27489052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe recalcitrant pyoderma gangrenosum treated with infliximab.
    Kaur MR; Lewis HM
    Br J Dermatol; 2005 Sep; 153(3):689-91. PubMed ID: 16120178
    [No Abstract]   [Full Text] [Related]  

  • 35. Late-onset pyoderma gangrenosum following surgical operation in a patient with malignant melanoma.
    Mori T; Hiraiwa T; Ohtsuka M; Yamamoto T
    J Dermatol; 2015 Jun; 42(6):650-1. PubMed ID: 25858495
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pustular pyoderma gangrenosum: an uncommon variant which is easily misdiagnosed.
    Chia MW; Teo L; Tay YK; Poh WT
    Dermatol Online J; 2008 Feb; 14(2):21. PubMed ID: 18700124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractory pyoderma gangrenosum treated with infliximab in an infant.
    Campos-Muñoz L; Conde-Taboada A; Aleo E; Toledano E; López-Bran E
    Clin Exp Dermatol; 2014 Apr; 39(3):336-9. PubMed ID: 24635074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
    Kim DW; Lee BI; Park SH
    Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyoderma Gangrenosum After Abdominal Free Tissue Transfer for Breast Reconstruction: Case Series and Management Guidelines.
    Li WY; Andersen JC; Jung J; Andersen JS
    Ann Plast Surg; 2019 Jul; 83(1):63-68. PubMed ID: 31095530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.